Esophagitis Global Clinical Trials Review, H1, 2015

Esophagitis Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2656CTIDB
  • |
  • Pages: 106
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Esophagitis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Esophagitis Global Clinical Trials Review, H1, 2015" provides data on the Esophagitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Esophagitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Esophagitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Esophagitis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Esophagitis to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Esophagitis to Gastrointestinal Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Esophagitis 25

Subjects Recruited Over a Period of Time 30

Clinical Trials by Sponsor Type 31

Prominent Sponsors 32

Top Companies Participating in Esophagitis Therapeutics Clinical Trials 33

Prominent Drugs 35

Clinical Trial Profiles 36

Clinical Trial Overview of Top Companies 36

AstraZeneca PLC 36

Clinical Trial Overview of AstraZeneca PLC 36

Takeda Pharmaceutical Company Limited 44

Clinical Trial Overview of Takeda Pharmaceutical Company Limited 44

Eisai Co., Ltd. 50

Clinical Trial Overview of Eisai Co., Ltd. 50

Johnson & Johnson 53

Clinical Trial Overview of Johnson & Johnson 53

Pfizer Inc. 55

Clinical Trial Overview of Pfizer Inc. 55

Indivior PLC 57

Clinical Trial Overview of Indivior PLC 57

Novartis AG 59

Clinical Trial Overview of Novartis AG 59

Shire Plc 60

Clinical Trial Overview of Shire Plc 60

Yuhan Corporation 61

Clinical Trial Overview of Yuhan Corporation 61

Dr. Reddy's Laboratories Limited 62

Clinical Trial Overview of Dr. Reddy's Laboratories Limited 62

Clinical Trial Overview of Top Institutes / Government 63

Mayo Clinic 63

Clinical Trial Overview of Mayo Clinic 63

Shimane University 64

Clinical Trial Overview of Shimane University 64

Academic Medical Center 65

Clinical Trial Overview of Academic Medical Center 65

The University of Utah 66

Clinical Trial Overview of The University of Utah 66

Cincinnati Children's Hospital Medical Center 67

Clinical Trial Overview of Cincinnati Children's Hospital Medical Center 67

Juntendo University School of Medicine 68

Clinical Trial Overview of Juntendo University School of Medicine 68

Osaka City University 69

Clinical Trial Overview of Osaka City University 69

Seoul National University Hospital 70

Clinical Trial Overview of Seoul National University Hospital 70

University of North Carolina 71

Clinical Trial Overview of University of North Carolina 71

Yokohama City University 72

Clinical Trial Overview of Yokohama City University 72

Five Key Clinical Profiles 73

Appendix 104

Abbreviations 104

Definitions 104

Research Methodology 105

Secondary Research 105

About GlobalData 106

Contact Us 106

Disclaimer 106

Source 106

List of Figures

Esophagitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Esophagitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Esophagitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Esophagitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Esophagitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Esophagitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Esophagitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Esophagitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Esophagitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Esophagitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Esophagitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Esophagitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Esophagitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Esophagitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Esophagitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Esophagitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Esophagitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Esophagitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Esophagitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Esophagitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31

Esophagitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Esophagitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Esophagitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 35

GlobalData Methodology 105

List of Tables

Esophagitis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Esophagitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Esophagitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Esophagitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Esophagitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Esophagitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Esophagitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Esophagitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Esophagitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Esophagitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Esophagitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Esophagitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Esophagitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Esophagitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Esophagitis Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Esophagitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Esophagitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Esophagitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Esophagitis Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Esophagitis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Esophagitis Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Esophagitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Esophagitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31

Esophagitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Esophagitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 34

Esophagitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 35

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 36

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 44

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 50

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 53

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 55

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Indivior PLC, 2015* 57

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 59

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2015* 60

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yuhan Corporation, 2015* 61

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2015* 62

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 63

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shimane University, 2015* 64

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 65

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2015* 66

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2015* 67

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015* 68

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka City University, 2015* 69

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 70

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of North Carolina, 2015* 71

Esophagitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2015* 72

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Esophagitis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Esophagitis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 161900
Site License
USD 5000 INR 323800
Corporate User License
USD 7500 INR 485700

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com